2019 | 2018 | 2017 | 2016 | All

Company News

Spiros Jamas

Spiros Jamas is the Senior Vice President of Therapeutic Development of our Company. He is primarily responsible for therapeutics strategy and development, clinical development and regulatory affairs. He co-founded AOBiome LLC in May 2013. He graduated from the University of Manchester, United Kingdom, with a Bachelor of Science majoring in Chemical Engineering, and from Massachusetts Institute of Technology, United States with a Master of Science majoring in food science and technology and a Doctor of Science majoring in Biotechnology.

Dr. Jamas has over 24 years of experience in the biopharmaceutical industry. From 1988 to 1999, he served as chief executive officer of Alpha-Beta Technology, Inc., a biotech company developing a first-in-class biologic immunomodulator, where he was responsible for its strategic development, clinical development and regulatory affairs. From 2001 to 2004, he served as chief executive officer of Enanta Pharmaceuticals, Inc., a biotech company which develops drugs for hepatitis C virus, where he was responsible for its strategic development and general management. From 2004 to 2009, he was a biotechnology/pharma analyst for the global fundamental strategies team of State Street Global Advisors, an asset management company, where he was responsible for stock analyses as well as clinical/regulatory due diligence. In 2010, he co-founded Tempero Pharmaceuticals, Inc., a biotech company which is now a part of the GlaxoSmithKline group, to develop drugs for inflammatory and autoimmune diseases.